MARKED MITIGATION OF TRANSPLANT VASCULAR SCLEROSIS IN FasLgld (CD95L) MUTANT RECIPIENTS

Transplantation - United States
doi 10.1097/00007890-199905270-00001
Full Text
Abstract

Available in full text

Categories
Transplantation
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search